Seraphina Wentworth
FDA approves Camizestrant for breast cancer with ESR1 mutations
The FDA approves camizestrant for ER-positive, HER2-negative metastatic breast cancer with ESR1 mutations. Learn about this new treatment option and its clinica
Adjunct Antipsychotics Offer Hope for Depression Treatment
Adjunct antipsychotics are emerging as a promising option for treating depression when antidepressants fall short, offering new hope for patients.
Mountain West Cancer Care Hampered by Distance, Telehealth
Cancer telehealth is bridging the vast distance barrier for Mountain West patients, offering remote specialist access and reducing travel hardships.
New Drug Reduces Heart Attack Risk
Evolocumab reduces heart attack risk by 20% in high-risk patients with atherosclerosis or diabetes, lowering mortality rates effectively.
DOJ Drops Olmstead Defense as Texas v. Kennedy Advances
The DOJ drops the Olmstead defense in Texas v. Kennedy, shifting from defending HHS rules to siding with states on Section 504…
Lung Cancer Task Force Maps Roadmap to Close Survival Gap
A new AACR Lung Cancer Task Force roadmap outlines key research priorities to close the survival gap and improve patient outcomes.
FDA Approves New Narcolepsy Treatment
FDA approves new narcolepsy treatment targeting orexin deficiency for narcolepsy type 1 patients.
Contributor highlights deadly gap in charity care
The tragic death of an uninsured patient exposes a charity care gap in the U.S., where essential outpatient services are denied, urging…
Trump pushes hospitals to release ER data
Trump administration pushes hospitals to release ER patient data, raising major privacy concerns among legal and health experts.
Mindful cooking for health and balance
Discover how mindful cooking transforms meals into a nourishing ritual for health and balance with simple, intentional steps.